IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
Basic Research in Cardiology · 2021-12 · 116 (1)
DOI: 10.1007/s00395-021-00893-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Basic Research in Cardiology, online erschienen am 13.09.2021. Verfasst von Sandrine Lecour und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, Cape Town, South Africa. Hauptthemen laut MEDLINE: Heart Failure, Myocardial Infarction, Reperfusion Injury. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, British Heart Foundation, European Cooperation in Science and Technology.
Abstract (Originalsprache)
Acute myocardial infarction (AMI) and the heart failure (HF) which may follow are among the leading causes of death and disability worldwide. As such, new therapeutic interventions are still needed to protect the heart against acute ischemia/reperfusion injury to reduce myocardial infarct size and prevent the onset of HF in patients presenting with AMI. However, the clinical translation of cardioprotective interventions that have proven to be beneficial in preclinical animal studies, has been challenging. One likely major reason for this failure to translate cardioprotection into patient benefit is the lack of rigorous and systematic in vivo preclinical assessment of the efficacy of promising cardioprotective interventions prior to their clinical evaluation. To address this, we propose an in vivo set of step-by-step criteria for IM proving P reclinical A ssessment of C ardioprotective T herapies (‘IMPACT’), for investigators to consider adopting before embarking on clinical studies, the aim of which is to improve the likelihood of translating novel cardioprotective interventions into the clinical setting for patient benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, Cape Town, South Africa.
- Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.
- The Hatter Cardiovascular Institute, University College London, London, UK.
- Institute for Pathophysiology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany.
- Cardiovascular Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Förderung
- Medical Research Council
- British Heart Foundation
- European Cooperation in Science and Technology
- Duke-National University Singapore Medical School
- South African Department of Science and Technology and the South African National Research Foundation
- German Research Foundation
- Spanish Institute of Health Carlos III
- Instituto de Salud Carlos III
Zitieren
APA
Lecour, S., Andreadou, I., Bøtker, H. E., Davidson, S. M., Heusch, G., Ruiz-Meana, M., Schulz, R., Zuurbier, C. J., Ferdinandy, P., Hausenloy, D. J., & on behalf of the European Union-CARDIOPROTECTION COST ACTION CA16225 (2021). IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action. Basic Research in Cardiology, 116(1). https://doi.org/10.1007/s00395-021-00893-5
Vancouver
Lecour S, Andreadou I, Bøtker HE, Davidson SM, Heusch G, Ruiz-Meana M, et al. IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action. Basic Research in Cardiology. 2021;116(1). doi:10.1007/s00395-021-00893-5
BibTeX
@article{Lecour2021,
author = {Lecour, Sandrine and Andreadou, Ioanna and Bøtker, Hans Erik and Davidson, Sean M and Heusch, Gerd and Ruiz-Meana, Marisol and Schulz, Rainer and Zuurbier, Coert J and Ferdinandy, Péter and Hausenloy, Derek J and on behalf of the European Union-CARDIOPROTECTION COST ACTION CA16225, on behalf of the European Union-CARDIOPROTECTION COST ACTION CA16225},
title = {IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action},
journal = {Basic Research in Cardiology},
year = {2021},
volume = {116},
number = {1},
doi = {10.1007/s00395-021-00893-5}
}
EUVIMED